Diabetes
| Interventional and Clinical Studies
Diabetes
Interventional and Clinical Studies
Tirzepatide vs. Semaglutide 2.4 mg for People with Obesity or Overweight and Type 2 Diabetes
book_2
Source:
ObesityWeek 2023 - Poster presentation
calendar_today
Published on Medfyle:
November 2023
In this medfyle
In patients with overweight and T2D or affected by obesity, this indirect treatment comparison between tirzepatide and liraglutide demonstrated greater efficacy with tirzepatide.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
This is a summary of a presentation given at the ObesityWeek®️ 2023.
The information and data provided is for information purposes only. The presenting author(s) of the original presentation had no involvement in the creation of this content.
©️2023 Infomedica-Medfyle. All rights reserved.
